ClinicalTrials.Veeva

Menu

PMS Retrospective Study of WIRION Performance in Patients Undergoing Saphenous Vein Graft (SVG) Intervention

G

Gardia Medical

Status

Completed

Conditions

Stenosis

Treatments

Device: Saphenous vein graft (SVG) stenting

Study type

Observational

Funder types

Industry

Identifiers

NCT02373852
SVG-CL003

Details and patient eligibility

About

The objective of this study is to collect data on the use of the WIRION system in Patients undergoing Percutaneous Intervention of Saphenous Vein Graft (SVG).

Full description

WIRION system is used as protection device in patients undergoing SVG stenting procedure. This retrospective study collects data on the usability of the WIRION during the procedure.

Enrollment

12 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients underwent percutaneous intervention (PI) of SVG stenting in which the WIRIONTM system was used.
  • Patient is greater than or equal to 18 years of age.

Exclusion criteria

  • Undergone cardiac surgery in the past 60 days before the procedure.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems